Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Robert DeHaven who wrote (166)	11/5/1997 8:30:00 PM
From: men mailman	Read Replies (1) \| Respond to of 2068

Yes oxhp is way oversold at 24 down from 78. With only 79 million shares outstanding the supply will dry up. I see a quick bounce to 30-40. As to the lawsuits never mind, it is much harder to win these days especially with the new laws enacted lately. I know many cases where these lawsuits were just thrown out or settled for a couple million dollars to get the lawyers of the back. At 24 these shares are very cheap. BTW anyone selling here is losing money and big money the weak and faint were already shaken out it is time now to ride the stock back to $40.

To: Robert DeHaven who wrote (166)	11/5/1997 8:31:00 PM
From: Zebra 365	Read Replies (3) \| Respond to of 2068

I agree that this stock is a buy at this price. In fact I have been buying and selling stocks for fourteen years and this is the first time I have used margin to load up. I happen to follow HMO's and PPM's very closely. Only a few months ago I was warning people to stay away from this one due to price and the lawsuit. No, not a shareholder's suit but the suit that OXHP lost which forced them to pay interest on claims not paid. Such suit by the way was public knowledge and the fact of that red flag will probably be a strong defense against shareholders claims that there was no clue that the company had troubles. When a health insurer is not paying claims, it usually is not to save money but is having problems with data. Aetna went through the same thing and got hit too, but not as bad. Data is the lifeblood to an insurer and that suit was a clear red flag to me. My scenario is that management did not publicize this information system problem until they had to, so that they could get the contracting done for 1998 first. Now the contracting is complete (usually done by October 1), so there will not be a large membership loss over this fiasco. So I see the top line being intact, extra reserves taken in this big hit to earnings, and the ship will sail on. Downside here is that, contracting being complete for 1998, they have not been able to raise rates after finding that utilization is higher than projected. So earnings will grow from here but not as fast as in 95-96. I factor that in and it still looks like a buy at this price. Do your own checking and DD but I agree this may prove to be a short lived opportunity to buy under 25. Zebra